Use of benzo-fused heterocycle sulfamide derivatives for the treatment of anxiety

Details for Australian Patent Application No. 2008353489 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Smith-Swintosky, Virginia L.

Agent Shelston IP

Pub. Number AU-A-2008353489

PCT Pub. Number WO2009/120189

Filing date 26 March 2008

Wipo publication date 1 October 2009

International Classifications

A61K 31/353 (2006.01)

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

Event Publications

14 October 2010 PCT application entered the National Phase

  PCT publication WO2009/120189 Priority application(s): WO2009/120189

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008353491-Process for the preparation of benzofused heteroaryl sulfamates and crystalline form of N- ( ( (2S) - 6-chloro-2,3-dihydro-l,4-benzodioxin-2yl) methyl-sulfamide

2008353479-Anti-VEGF antibody